Arrowstreet Capital, Limited Partnership Merck & Co., Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Merck & Co., Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 6,207,199 shares of MRK stock, worth $611 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
6,207,199
Previous 4,747,708
30.74%
Holding current value
$611 Million
Previous $626 Million
22.67%
% of portfolio
0.68%
Previous 0.58%
Shares
28 transactions
Others Institutions Holding MRK
# of Institutions
3,803Shares Held
1.9BCall Options Held
13.5MPut Options Held
11.1M-
Vanguard Group Inc Valley Forge, PA250MShares$24.6 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.4 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$11.6 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$7.14 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.83 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $250B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...